Close Menu

Somalogic

NEW YORK (GenomeWeb News) – SomaLogic, New England Biolabs, and Gilead Sciences are suing Enzymatics in federal court for patent infringement.

Proteomics diagnostics firm Somalogic reported data this week supporting the utility of its blood-based 13-protein panel for the detection of malignant mesothelioma.

Quest Diagnostics has begun offering a test for measuring free epidermal growth factor receptor using Somalogic's aptamer-based Somamer technology.

Life Technologies said this week that it plans to accelerate development of its Ion Torrent technology for proteomic applications.

SomaLogic has released SomaSuite, a software tool that provides access to multiplexed proteomic data generated by SomaLogic's Somascan proteomics assay technology.

Aushon Biosystems announced this week its plans to launch a new multiplex protein biomarker platform.

By Adam Bonislawski
Somalogic last week published in PLoS One a study offering the first data on use of its aptamer-based Somascan platform in tissue samples.

By Adam Bonislawski
Researchers at the University of Pittsburgh Cancer Institute have identified a panel of ten serum protein markers that could be used in risk assessment and the early detection of lung cancer.

Pages

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.